GlassScriptPhysician profile
Madison Nash
NPI 1851003966
$265.41
in general payments reported to CMS, 2019-2025
8 companies · $50.65 in 2025
The $50.65 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $141 · 2024: $74.05 · 2025: $50.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $59.37 | 2024 | Bexsero, Shingrix, Arexvy |
| Organon LLC | $48.73 | 2023 | Nexplanon |
| Aimmune Therapeutics, INC. | $46.89 | 2024-2025 | Zenpep |
| Alkermes, INC. | $28.64 | 2023 | Vivitrol |
| Celgene Corporation | $23.19 | 2023 | Zeposia |
| Merck Sharp & Dohme LLC | $21.72 | 2023 | Gardasil 9, Vaxelis, Rotateq |
| Celltrion USA INC. | $18.44 | 2025 | Vegzelma |
| Sanofi Pasteur INC. | $18.43 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Nash listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.